Sex steroids and bone health status in men

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Chin, Kok Yong ^a   Ima Nirwana, Soelaiman ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; TESTOSTERONE;

AGE; ANDROGEN DEFICIENCY; BONE DENSITY; BONE REMODELING; ECHOGRAPHY; ENZYME DEFICIENCY; FRACTURE; HEALTH STATUS; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOGONADISM; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 84870157468     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/208719     Document Type: Review

References (68)

1. Riggs B. L., Khosla S., Melton L. J., Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews 2002 23 3 279 302 2-s2.0-0035985305 10.1210/er.23.3.279 (Pubitemid 34651948)
2. Chin K.-Y., Ima-Nirwana S., Isa Naina M., Norazlina M., Ahmad Nazrun S., Norliza M., Faizah O., Farihah H. S., Elvy Suhana M. R., Wan Zurinah W. N., Calcaneal quantitative ultrasound value for middle-aged and elderly malaysian Chinese men and its association with age and body anthropometry. Journal of Clinical Densitometry 2012 15 1 86 91 2-s2.0-84856324432 10.1016/j.jocd.2011.09. 004
3. Donaldson L. J., Reckless I. P., Scholes S., Mindell J. S., Shelton N. J., The epidemiology of fractures in England. Journal of Epidemiology and Community Health 2008 62 2 174 180 2-s2.0-38849115077 10.1136/jech.2006.056622 (Pubitemid 351196859)
4. Van Staa T. P., Dennison E. M., Leufkens H. G. M., Cooper C., Epidemiology of fractures in England and Wales. Bone 2001 29 6 517 522 2-s2.0-0035208925 10.1016/S8756-3282(01)00614-7 (Pubitemid 33124293)
5. Gielen E., Vanderschueren D., Callewaert F., Boonen S., Osteoporosis in men. Best Practice and Research 2011 25 2 321 335 2-s2.0-79952560131 10.1016/j.beem.2010.08.012
6. Johnell O., Kanis J. A., An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006 17 12 1726 1733 2-s2.0-33750209491 10.1007/s00198-006-0172-4 (Pubitemid 44607392)
7. Bliuc D., Nguyen N. D., Milch V. E., Nguyen T. V., Eisman J. A., Center J. R., Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009 301 5 513 521 2-s2.0-59649116770 10.1001/jama.2009.50
8. Papaioannou A., Kennedy C. C., Ioannidis G., Sawka A., Hopman W. M., Pickard L., Brown J. P., Josse R. G., Kaiser S., Anastassiades T., Goltzman D., Papadimitropoulos M., Tenenhouse A., Prior J. C., Olszynski W. P., Adachi J. D., The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporosis International 2009 20 5 703 714 2-s2.0-63949085680 10.1007/s00198-008-0743-7
9. Burge R., Dawson-Hughes B., Solomon D. H., Wong J. B., King A., Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. Journal of Bone and Mineral Research 2007 22 3 465 475 2-s2.0-34247194211 10.1359/jbmr.061113 (Pubitemid 46797130)
10. Vanderschueren D., Vandenput L., Boonen S., Lindberg M. K., Bouillon R., Ohlsson C., Androgens and bone. Endocrine Reviews 2004 25 3 389 425 2-s2.0-2942736921 10.1210/er.2003-0003 (Pubitemid 38786452)
11. Kang H. Y., Cho C. L., Huang K. L., Wang J. C., Hu Y. C., Lin H. K., Chang C., Huang K. E., Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. Journal of Bone and Mineral Research 2004 19 7 1181 1190 2-s2.0-16544387699 10.1359/JBMR.040306 (Pubitemid 41110571)
12. Balkan W., Burnstein K. L., Schiller P. C., Perez-Stable C., D'Ippolito G., Howard G. A., Roos B. A., Androgen-induced mineralization by MC3T3-E1 osteoblastic cells reveals a critical window of hormone responsiveness. Biochemical and Biophysical Research Communications 2005 328 3 783 789 2-s2.0-13444249703 10.1016/j.bbrc.2004.12.090 (Pubitemid 40208317)
13. Wiren K. M., Evans A. C., Zhang X. W., Osteoblast differentiation influences androgen and estrogen receptor- α and-β expression. Journal of Endocrinology 2002 175 3 683 694 2-s2.0-0036936648 10.1677/joe.0.1750683
14. Chen Q., Kaji H., Sugimoto T., Chihara K., Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. FEBS Letters 2001 491 1-2 91 93 2-s2.0-0035936857 10.1016/S0014- 5793(01)02160-3 (Pubitemid 32172008)
15. Pederson L., Kremer M., Judd J., Pascoe D., Spelsberg T. C., Riggs B. L., Oursler M. J., Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proceedings of the National Academy of Sciences of the United States of America 1999 96 2 505 510 2-s2.0-0033582237 10.1073/pnas.96.2.505 (Pubitemid 29061238)
16. Pilbeam C. C., Raisz L. G., Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae. Journal of Bone and Mineral Research 1990 5 11 1183 1188 2-s2.0-0025147679 (Pubitemid 20373527)
17. Bellido T., Jilka R. L., Boyce B. F., Girasole G., Broxmeyer H., Dalrymple S. A., Murray R., Manolagas S. C., Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. The Journal of Clinical Investigation 1995 95 6 2886 2895 2-s2.0-0029051331
18. Venken K., De Gendt K., Boonen S., Ophoff J., Bouillon R., Swinnen J. V., Verhoeven G., Vanderschueren D., Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. Journal of Bone and Mineral Research 2006 21 4 576 585 2-s2.0-33645329097 10.1359/jbmr.060103
19. Yarrow J. F., Conover C. F., Purandare A. V., Bhakta A. M., Zheng N., Conrad B., Altman M. K., Franz S. E., Wronski T. J., Borst S. E., Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. American Journal of Physiology 2008 295 5 E1213 E1222 2-s2.0-57049105723 10.1152/ajpendo.90640. 2008
20. Chiang C., Chiu M., Moore A. J., Anderson P. H., Ghasem-Zadeh A., McManus J. F., Cathy M., Seeman E., Clemens T. L., Morris H. A., Zajac J. D., Davey R. A., Mineralization and bone resorption are regulated by the androgen receptor in male mice. Journal of Bone and Mineral Research 2009 24 4 621 631 2-s2.0-65549171025 10.1359/jbmr.081217
21. Amory J. K., Watts N. B., Easley K. A., Sutton P. R., Anawalt B. D., Matsumoto A. M., Bremner W. J., Tenover J. L., Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. Journal of Clinical Endocrinology and Metabolism 2004 89 2 503 510 2-s2.0-1442278883 10.1210/jc.2003-031110 (Pubitemid 38269849)
22. Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto A. M., Snyder P. J., Weber T., Berman N., Hull L., Swerdloff R. S., Long-Term Testosterone Gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2004 89 5 2085 2098 2-s2.0-2442543161 10.1210/jc.2003-032006 (Pubitemid 38619836)
23. Benito M., Vasilic B., Wehrli F. W., Bunker B., Wald M., Gomberg B., Wright A. C., Zemel B., Cucchiara A., Snyder P. J., Effect of testosterone replacement on trabecular architecture in hypogonadal men. Journal of Bone and Mineral Research 2005 20 10 1785 1791 2-s2.0-25444504798 10.1359/JBMR.050606 (Pubitemid 41361879)
24. Diamond T. H., Higano C. S., Smith M. R., Guise T. A., Singer F. R., Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 2004 100 5 892 899 2-s2.0-1242336807 10.1002/cncr.20056 (Pubitemid 38222847)
25. Shahinian V. B., Kuo Y. F., Freeman J. L., Goodwin J. S., Risk of fracture after androgen deprivation for prostate cancer. The New England Journal of Medicine 2005 352 2 154 164 2-s2.0-11844252588 10.1056/NEJMoa041943 (Pubitemid 40096612)
26. Bruder J. M., Ma J. Z., Basler J. W., Welch M. D., Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy. Urology 2006 67 1 152 155 2-s2.0-30344468795 10.1016/j.urology.2005.07.017 (Pubitemid 43069275)
27. Kaufman J. M., Vermeulen A., The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005 26 6 833 876 2-s2.0-26444515048 10.1210/er.2004-0013 (Pubitemid 41428540)
28. Morales A., Schulman C. C., Tostain J., C.W. Wu F. F., Testosterone Deficiency Syndrome (TDS) needs to be named appropriately-the importance of accurate terminology. European Urology 2006 50 3 407 409 2-s2.0-33746905956 10.1016/j.eururo.2006.07.001 (Pubitemid 44192565)
29. Harman S. M., Metter E. J., Tobin J. D., Pearson J., Blackman M. R., Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Journal of Clinical Endocrinology and Metabolism 2001 86 2 724 731 2-s2.0-0035097033 10.1210/jc.86.2.724 (Pubitemid 32207487)
30. Feldman H. A., Longcope C., Derby C. A., Johannes C. B., Araujo A. B., Coviello A. D., Bremner W. J., McKinlay J. B., Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism 2002 87 2 589 598 2-s2.0-0036170745 10.1210/jc.87.2.589 (Pubitemid 34158223)
31. Liu P. Y., Beilin J., Meier C., Nguyen T. V., Center J. R., Leedman P. J., Seibel M. J., Eisman J. A., Handelsman D. J., Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. Journal of Clinical Endocrinology and Metabolism 2007 92 9 3599 3603 2-s2.0-34548722899 10.1210/jc.2007-0862 (Pubitemid 47435341)
32. Travison T. G., Araujo A. B., Kupelian V., O'Donnell A. B., McKinlay J. B., The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 2007 92 2 549 555 2-s2.0-33846961810 10.1210/jc.2006-1859
33. Khosla S., Melton L. J., Atkinson E. J., O'Fallon W. M., Klee G. G., Riggs B. L., Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. Journal of Clinical Endocrinology and Metabolism 1998 83 7 2266 2274 2-s2.0-0031756218 10.1210/jc.83.7.2266 (Pubitemid 28503012)
34. Van Den Beld A. W., De Jong F. H., Grobbee D. E., Pols H. A. P., Lamberts S. W. J., Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism 2000 85 9 3276 3282 2-s2.0-0033678650
35. Amin S., Zhang Y., Sawin C. T., Evans S. R., Hannan M. T., Kiel D. P., Wilson P. W. F., Felson D. T., Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Annals of Internal Medicine 2000 133 12 951 963 2-s2.0-0034687826 (Pubitemid 32003511)
36. Szulc P., Claustrat B., Marchand F., Delmas P. D., Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5240 5247 2-s2.0-0344874544 10.1210/jc.2003-030200 (Pubitemid 37452722)
37. Khosla S., Melton L. J., Robb R. A., Camp J. J., Atkinson E. J., Oberg A. L., Rouleau P. A., Riggs B. L., Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. Journal of Bone and Mineral Research 2005 20 5 730 740 2-s2.0-17644366424 10.1359/JBMR.041228 (Pubitemid 40571629)
38. Mellström D., Johnell O., Ljunggren Ö., Eriksson A. L., Lorentzon M., Mallmin H., Holmberg A., Redlund-Johnell I., Orwoll E., Ohlsson C., Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. Journal of Bone and Mineral Research 2006 21 4 529 535 2-s2.0-33645333405 10.1359/jbmr.060110
39. Araujo A. B., Travison T. G., Leder B. Z., McKinlay J. B., Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. Journal of Clinical Endocrinology and Metabolism 2008 93 6 2135 2141 2-s2.0-45149127774 10.1210/jc.2007-1469 (Pubitemid 351831527)
40. LeBlanc E. S., Nielson C. M., Marshall L. M., Lapidus J. A., Barrett-Connor E., Ensrud K. E., Hoffman A. R., Laughlin G., Ohlsson C., Orwoll E. S., The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3337 3346 2-s2.0-69949092976 10.1210/jc.2009-0206
41. Travison T. G., Araujo A. B., Beck T. J., Williams R. E., Clark R. V., Leder B. Z., McKinlay J. B., Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. Journal of Clinical Endocrinology and Metabolism 2009 94 3 853 860 2-s2.0-62349130747 10.1210/jc.2008-0668
42. Paller C. J., Shiels M. S., Rohrmann S., Basaria S., Rifai N., Nelson W., Platz E. A., Dobs A., Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clinical Endocrinology 2009 70 1 26 34 2-s2.0-58149157618 10.1111/j.1365-2265.2008.03300. x
43. Venkat K., Desai M., Arora M. M., Singh P., Khatkhatay M. I., Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. Osteoporosis International 2009 20 6 955 962 2-s2.0-67349272714 10.1007/s00198-008-0765-1
44. Woo J., Kwok T., Leung J. C. S., Ohlsson C., Vandenput L., Leung P. C., Sex steroids and bone health in older Chinese men. Osteoporosis International 2011 1 10 2-s2.0-79751538785 10.1007/s00198-011-1552-y
45. Chen H., Hardy M. P., Huhtaniemi I., Zirkin B. R., Age-related decreased Leydig cell testosterone production in the Brown Norway rat. Journal of Andrology 1994 15 6 551 557 2-s2.0-0028558510
46. Chen H., Hardy M. P., Zirkin B. R., Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro. Endocrinology 2002 143 5 1637 1642 2-s2.0-0036227563 10.1210/en.143.5.1637 (Pubitemid 34415877)
47. Chen H., Irizarry R. A., Luo L., Zirkin B. R., Leydig cell gene expression: effects of age and caloric restriction. Experimental Gerontology 2004 39 1 31 43 2-s2.0-0347318172 10.1016/j.exger.2003.09.021 (Pubitemid 38068257)
48. Erfurth E. M. T., Hagmar L. E., Sääf M., Hall K., Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clinical Endocrinology 1996 44 6 659 664 2-s2.0-0029955199 (Pubitemid 26225181)
49. Pfeilschifter J., Scheidt-Nave C., Leidig-Bruckner G., Woitge H. W., Blum W. F., Wüster C., Haack D., Ziegler R., Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. Journal of Clinical Endocrinology and Metabolism 1996 81 7 2534 2540 2-s2.0-0030011396 10.1210/jc.81.7.2534 (Pubitemid 26240273)
50. Khosla S., Melton L. J., Atkinson E. J., O'Fallon W. M., Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3555 3561 2-s2.0-0034890081 10.1210/jc.86.8.3555 (Pubitemid 32755943)
51. Gennari L., Nuti R., Bilezikian J. P., Aromatase activity and bone homeostasis in men. Journal of Clinical Endocrinology and Metabolism 2004 89 12 5898 5907 2-s2.0-10344253290 10.1210/jc.2004-1717 (Pubitemid 39628389)
52. Khosla S., Oursler M. J., Monroe D. G., Estrogen and the skeleton. Trends in Endocrinology & Metabolism 2012 23 11 576 581
53. Smith E. P., Boyd J., Frank G. R., Takahashi H., Cohen R. M., Specker B., Williams T. C., Lubahn D. B., Korach K. S., Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England Journal of Medicine 1994 331 16 1056 1061 2-s2.0-0028143234 10.1056/NEJM199410203311604 (Pubitemid 24317698)
54. Morishima A., Grumbach M. M., Simpson E. R., Fisher C., Qin K., Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 12 3689 3698 2-s2.0-0028792229
55. Bilezikian J. P., Morishima A., Bell J., Grumbach M. M., Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. The New England Journal of Medicine 1998 339 9 599 603 2-s2.0-0032572929 10.1056/NEJM199808273390905 (Pubitemid 28385657)
56. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K. S., Simpson E. R., Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine 1997 337 2 91 95 2-s2.0-0030797569 10.1056/NEJM199707103370204 (Pubitemid 27284394)
57. Herrmann B. L., Saller B., Janssen O. E., Gocke P., Bockisch A., Sperling H., Mann K., Broecker M., Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. Journal of Clinical Endocrinology and Metabolism 2002 87 12 5476 5484 2-s2.0-0036925191 10.1210/jc.2002-020498 (Pubitemid 36034347)
58. Lanfranco F., Zirilli L., Baldi M., Pignatti E., Corneli G., Ghigo E., Aimaretti G., Carani C., Rochira V., A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone 2008 43 3 628 635 2-s2.0-49149120444 10.1016/j.bone.2008.05.011
59. Bouillon R., Bex M., Vanderschueren D., Boonen S., Estrogens are essential for male pubertal periosteal bone expansion. Journal of Clinical Endocrinology and Metabolism 2004 89 12 6025 6029 2-s2.0-10344262585 10.1210/jc.2004-0602 (Pubitemid 39628410)
60. Miyaura C., Toda K., Inada M., Ohshiba T., Matsumoto C., Okada T., Ito M., Shizuta Y., Ito A., Sex- and age-related response to aromatase deficiency in bone. Biochemical and Biophysical Research Communications 2001 280 4 1062 1068 2-s2.0-0034810949 10.1006/bbrc.2001.4246 (Pubitemid 32924448)
61. Matsumoto C., Inada M., Toda K., Miyaura C., Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone 2006 38 2 220 226 2-s2.0-31544474860 10.1111/j.1540-8159.2006. 00326.x
62. Senanarong V., Vannasaeng S., Poungvarin N., Ploybutr S., Udompunthurak S., Jamjumras P., Fairbanks L., Cummings J. L., Endogenous estradiol in elderly individuals: cognitive and noncognitive associations. Archives of Neurology 2002 59 3 385 389 2-s2.0-0036186427 (Pubitemid 34208145)
63. Bjornerem Å., Straume B., Midtby M., Fonnebo V., Sundsfjord J., Svartberg J., Acharya G., Oian P., Berntsen G. K. R., Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso study. Journal of Clinical Endocrinology and Metabolism 2004 89 12 6039 6047 2-s2.0-10344234199 10.1210/jc.2004-0735 (Pubitemid 39628412)
64. Kuchuk N. O., Van Schoor N. M., Pluijm S. M. F., Smit J. H., De Ronde W., Lips P., The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women. Clinical Endocrinology 2007 67 2 295 303 2-s2.0-34447550380 10.1111/j.1365-2265.2007.02882.x (Pubitemid 47076310)
65. Chin K.-Y., Soelaiman I.-N., Mohamed I. N., Ngah W. Z. W., Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics 2012 67 8 911 916 2-s2.0-84866309879 10.6061/clinics/2012(08)10
66. Guglielmi G., de Terlizzi F., Quantitative Ultrasond in the assessment of Osteoporosis. European Journal of Radiology 2009 71 3 425 431 2-s2.0-69849109989 10.1016/j.ejrad.2008.04.060
67. Falahati-Nini A., Riggs B. L., Atkinson E. J., O'Fallon W. M., Eastell R., Khosla S., Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. The Journal of Clinical Investigation 2000 106 12 1553 1560 2-s2.0-0034521393 (Pubitemid 32038592)
68. Fatayerji D., Eastell R., Age-related changes in bone turnover in men. Journal of Bone and Mineral Research 1999 14 7 1203 1210 2-s2.0-0033014787 10.1359/jbmr.1999.14.7.1203 (Pubitemid 29314065)